Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361920 · ClinicalTrials.gov registry record · NA
Cell Biology of Steroid Resistant Asthma
A NA study, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00361920 is a NA study that has completed, run by National Jewish Health. The registered enrollment target is 40 participants.
The verdict
NCT00361920, a NA study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The hypothesis is that patients who demonstrate steroid resistant asthma by showing little or no improvement in lung function after a course of oral steroids have different cellular responses to steroids than patients who are steroid sensitive. These altered responses are the reason they demonstrate steroid resistance.
Interventions
- DRUG prednisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-08 |
| Est. Completion | 2007-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00361920
The ClinicalTrials.gov registry entry for NCT00361920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which prednisone is the first listed.
NCT00361920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00361920 about?
NCT00361920 is a clinical study titled "Cell Biology of Steroid Resistant Asthma". The hypothesis is that patients who demonstrate steroid resistant asthma by showing little or no improvement in lung function after a course of oral steroids have different cellular responses to steroids than patients who are steroid sensitive. These altered responses are the reason they demonstrate...
What is the current status of trial NCT00361920?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2006-08. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00361920?
The interventions under investigation include: prednisone (DRUG).
Who is sponsoring clinical trial NCT00361920?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.